Clinical Trial Update: The Jules Bordet Institute Molecular Profiling Program Feasibility Trial [NA]

View source ↗

Summary

Feasibility trial update from the Jules Bordet Institute molecular profiling program; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Colorectal Cancer Metastatic, Metastatic Melanoma | NA | Status: COMPLETED